Exposure of Mesenchymal Stem Cells to an Alzheimer's Disease Environment Enhances Therapeutic Effects

Mesenchymal stem cells (MSCs) have emerged as a promising tool for the treatment of Alzheimer's disease (AD). Previous studies suggested that the coculture of human MSCs with AD in an in vitro model reduced the expression of amyloid-beta 42 (Aβ42) in the medium as well as the overexpression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sang Eon, Kim, Hyeong Seop, Kwon, Soo Jin, Kim, Min-Jeong, Choi, Suk-joo, Oh, Soo-young, Ryu, Gyu Ha, Jeon, Hong Bae, Na, Duk L., Chang, Jong Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988745/
https://www.ncbi.nlm.nih.gov/pubmed/33815510
http://dx.doi.org/10.1155/2021/6660186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988745/
https://www.ncbi.nlm.nih.gov/pubmed/33815510
http://dx.doi.org/10.1155/2021/6660186

Ejemplares similares